Overview

Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This trial is going to evaluate tumor control and quality of life in patients with prostate cancer treated with endocrine therapy with or without cryoablation.
Phase:
N/A
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Collaborators:
Peking University First Hospital
Shandong Cancer Hospital and Institute
Shanghai Jiao Tong University School of Medicine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Third Xiangya Hospital of Central South University
Tianjin First Central Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Treatments:
Bicalutamide
Hormones
Prolactin Release-Inhibiting Factors